AI-driven technology detects mpox and monitors skin lesions in real-time, enhancing public health responses.
Background/Objectives: Mpox, a viral disease marked by distinctive skin lesions, has emerged as a global health concern, underscoring the need for scalable, accessible, and accurate diagnostic tools to strengthen public health responses. This study introduces ITMA’INN, an AI-driven healthcare system designed to detect Mpox from skin lesion images using advanced deep learning. Methods: The system integrates three key components: an AI model pipeline, a cross-platform mobile application, and a real-time public health dashboard. We leveraged transfer learning on publicly available datasets to evaluate pretrained deep learning models. Results: For binary classification (Mpox vs. non-Mpox), Vision Transformer, MobileViT, Transformer-in-Transformer, and VGG16 achieved peak performance, each with 97.8% accuracy and F1-score. For multiclass classification (Mpox, chickenpox, measles, hand-foot-mouth disease, cowpox, and healthy skin), ResNetViT and ViT Hybrid models attained 92% accuracy (F1-scores: 92.24% and 92.19%, respectively). The lightweight MobileViT was deployed in a mobile app that enables users to analyze skin lesions, track symptoms, and locate nearby healthcare centers via GPS. Complementing this, the dashboard equips health authorities with real-time case monitoring, symptom trend analysis, and intervention guidance. Conclusions: By bridging AI diagnostics with mobile technology and real-time analytics, ITMA’INN advances responsive healthcare infrastructure in smart cities, contributing to the future of proactive public health management.
No takes yet. Share an insight, caveat, or question.
Alghoraibi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: